WuXi Biologics is a global biologics contract development and manufacturing organization (CDMO) offering end-to-end solutions from discovery through commercial manufacturing. The company specializes in mammalian and microbial production platforms, CMC development, analytical sciences, and regulatory support to accelerate biologics programs from concept to commercialization. With capabilities spanning antibody discovery, protein production and engineering, process development, characterization, biosafety testing, and large-scale manufacturing, WuXi Biologics serves biopharma companies worldwide. Its operations cover multiple facilities across regions to support clinical and commercial biologics manufacturing.
No recent deals for this company.